Primary liver cancer spectrum:current knowledge and the next steps  

作　　者：Mohammad Saeid Rezaee-Zavareh Ekaterina K.Koltsova Yujin Hoshida Ju Dong Yang 

机构地区：[1]Middle East Liver Diseases Center,Tehran,Iran [2]Cedars-Sinai Cancer,Smidt Heart Institute,Cedars-Sinai Medical Center,Los Angeles,CA,USA [3]Division of Digestive and Liver Diseases,Department of Internal Medicine,University of Texas Southwestern Medical Center,Dallas,TX,USA [4]Karsh Division of Gastroenterology and Hepatology,Cedars-Sinai Medical Center,Los Angeles,CA,USA [5]Comprehensive Transplant Center,Cedars-Sinai Medical Center,Los Angeles,CA,USA [6]Samuel Oschin Comprehensive Cancer Institute,Cedars-Sinai Medical Center,Los Angeles,CA,USA

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第1期157-160,共4页肝胆外科与营养（英文）

摘　　要：Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(iCCA)constitute the main subtypes of primary liver cancers(PLCs)as a major cause of cancer-related mortality and incidence.They emerge from varying quantities and levels of differentiation among major liver cells,comprising hepatocytes,mucin-or non-mucin-producing cholangiocytes,and hepatic progenitor cells(HPCs)with the capability to differentiate into either hepatocytes or cholangiocytes.

关 键 词：Liver cancer spectrum hepatocellular carcinoma(HCC) cholangiocarcinoma(CCA) integrated analysis 

分 类 号：R735.7[医药卫生—肿瘤]